This study demonstrates that KIR2DS4 and its variant KIR1D are associated with outcomes for patients with a donors with KIR gene haplotype A in HSCT involving HLA-identical siblings.
KIR2DS4/KIR1D subclassification is helpful for donor selection in recipients of sibling-related HLA-matched HSCT.